Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for Diabetic Ketoacidosis
NCT03717896Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Nov 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiamine in diabetic ketoacidosis (DKA), sponsored by Beth Israel Deaconess Medical Center. Started Nov 2018; status: completed.
02
Drugs
thiamine
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on NCT03717896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717896.